✦ LIBER ✦

The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan

✍ Scribed by Naoki Hiramatsu; Akinori Kasahara; Fumihiko Nakanishi; Takashi Toyama; Masahiko Tsujii; Shingo Tsuji; Tatsuya Kanto; Tetsuo Takehara; Michio Kato; Harumasa Yoshihara; Masafumi Naito; Kazuhiro Katayama; Taizo Hijioka; Hideki Hagiwara; Shinji Kubota; Masahide Oshita; Haruya Meren; Manabu Masuzawa; Yoshimichi Haruna; Eiji Mita; Kunio Suzuki; Norio Hayashi

Book ID: 108138187
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 115 KB
Volume: 29
Category: Article
ISSN: 1386-6346
DOI: 10.1016/j.hepres.2004.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Efficacy of re-treatment with pegylated

Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 297 KB

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB

Immunological predictors of different re

Immunological predictors of different responses to combination therapy with interferon α and ribavirin in patients with chronic hepatitis C

✍ Ravdan Amaraa; Helena Mareckova; Petr Urbanek; Terezie Fucikova 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 215 KB